L W Myers|G W Ellison|M Lucia|S Novom - JoVE Visualize

Showing results (11-20 of 297) with videos related to

Pageof 30

Sort By:

Journal of Clinical Immunology|March 1, 1989

In vitro study of mediators of inflammation in multiple sclerosisJ E Merrill, S R Strom, G W Ellison, et al.

Journal of the Neurological Sciences|November 1, 1977

Histocompatibility types and measles antibodies in multiple sclerosisM E Fewster, L W Myers, G W Ellison, et al.

Neurology|August 1, 1975

Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosisM E Fewster, G W Ellison, L W Myers, et al.

Journal of Neuroimmunology|June 1, 1983

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferonJ E Merrill, R H Gerner, L W Myers, et al.

Neurology|November 1, 1987

Evoked potentials predict the clinical changes in a multiple sclerosis drug studyM R Nuwer, J W Packwood, L W Myers, et al.

Electroencephalography and Clinical Neurophysiology|January 1, 1988

A parametric scale for BAEP latencies in multiple sclerosisM R Nuwer, J W Packwood, G W Ellison, et al.

International Journal of Immunopharmacology|January 1, 1991

Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: studies in patients with chronic progressive multiple sclerosisF Chiappelli, L W Myers, G W Ellison, et al.

Advances in Alcohol & Substance Abuse|January 1, 1987

Delta-9-THC in the treatment of spasticity associated with multiple sclerosisJ T Ungerleider, T Andyrsiak, L Fairbanks, et al.

Journal of Neuroscience Research|December 18, 2001

T-cell responses to oligodendrocyte-specific protein in multiple sclerosisT Vu, L W Myers, G W Ellison, et al.

Journal of Neuroimmunology|March 1, 1987

Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parametersD J Moody, J Kagan, D Liao, et al.

Pageof 30

Showing results (11-20 of 297) with videos related to

Sort By:

Pageof 30

Journal of Clinical Immunology|March 1, 1989

In vitro study of mediators of inflammation in multiple sclerosisJ E Merrill, S R Strom, G W Ellison, et al.

Journal of the Neurological Sciences|November 1, 1977

Histocompatibility types and measles antibodies in multiple sclerosisM E Fewster, L W Myers, G W Ellison, et al.

Neurology|August 1, 1975

Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosisM E Fewster, G W Ellison, L W Myers, et al.

Journal of Neuroimmunology|June 1, 1983

Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 1. Association between amount of prostaglandin produced, natural killer, and endogenous interferonJ E Merrill, R H Gerner, L W Myers, et al.

Neurology|November 1, 1987

Evoked potentials predict the clinical changes in a multiple sclerosis drug studyM R Nuwer, J W Packwood, L W Myers, et al.

Electroencephalography and Clinical Neurophysiology|January 1, 1988

A parametric scale for BAEP latencies in multiple sclerosisM R Nuwer, J W Packwood, G W Ellison, et al.

International Journal of Immunopharmacology|January 1, 1991

Preferential reductions in lymphocyte sub-populations induced by monthly pulses of chlorambucil: studies in patients with chronic progressive multiple sclerosisF Chiappelli, L W Myers, G W Ellison, et al.

Advances in Alcohol & Substance Abuse|January 1, 1987

Delta-9-THC in the treatment of spasticity associated with multiple sclerosisJ T Ungerleider, T Andyrsiak, L Fairbanks, et al.

Journal of Neuroscience Research|December 18, 2001

T-cell responses to oligodendrocyte-specific protein in multiple sclerosisT Vu, L W Myers, G W Ellison, et al.

Journal of Neuroimmunology|March 1, 1987

Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parametersD J Moody, J Kagan, D Liao, et al.

Pageof 30